Dosierung von Antiinfektiva bei Nierenversagen und Nierenersatztherapie in der Intensivmedizin
Tóm tắt
Từ khóa
#thuốc kháng khuẩn #tổn thương thận cấp #liệu pháp thay thế thận #điều chỉnh liều #dược động học #dược lực họcTài liệu tham khảo
Ambrose PG, Bhavnani SM, Rubino CM, Louie A, Gumbo T, Forrest A, Drusano GL (2007) Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it’s not just for mice anymore. Clin Infect Dis 44:79–86
Bellmann R, Egger P, Gritsch W, Bellmann-Weiler R, Joannidis M, Dunzendorfer S, Wiedermann CJ (2002) Elimination of levofloxacin in critically ill patients with renal failure: influence of continuous veno-venous hemofiltration. Int J Clin Pharmacol Ther 40:142–149
Beumier M, Casu GS, Hites M, Seyler L, Cotton F, Vincent JL, Jacobs F, Taccone FS (2014) β‑lactam antibiotic concentrations during continuous renal replacement therapy. Crit Care 18:R105
Blot SI, Pea F, Lipman J (2014) The effect of pathophysiology on pharmacokinetics in the critically ill patient—concepts appraised by the example of antimicrobial agents. Adv Drug Deliv Rev 77:3–11
Bosso JA, Nappi J, Rudisill C, Wellein M, Bookstaver PB, Swindler J, Mauldin PD (2011) Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial. Antimicrob Agents Chemother 55:5475–5479
Cox ZL, McCoy AB, Matheny ME, Bhave G, Peterson NB, Siew ED, Lewis J, Danciu I, Bian A, Shintani A, Ikizler TA, Neal EB, Peterson JF (2013) Adverse drug events during AKI and its recovery. Clin. J Am Soc Nephrol 8:1070–1078
Czock D, Keller F (2014) Antibiotikadosierung bei Dialysepatienten. Nephrologe 9:477–487
Czock D, Keller F, Paar WD, Thalhammer F (2008) Nierenersatztherapie beim kritisch Kranken. Soll man Antibiotika bei kontinuierlicher Hämofiltration anders dosieren? Intensiv- und. Notfallbehandlung, Bd. 33, S 169–183
Czock D, Markert C, Hartman B, Keller F (2009) Pharmacokinetics and pharmacodynamics of antimicrobial drugs. Expert Opin Drug Metab. Toxicol, Bd. 5, S 475–487
Czock D, Spitaletta M, Keller F (2015) Suboptimal antimicrobial drug exposure in patients with renal impairment. Int J Clin Pharm 37:906–916
Dettli L (1976) Drug dosage in renal disease. Clin Pharmacokinet 1:126–134
Friedrich JO, Wald R, Bagshaw SM, Burns KE, Adhikari NK (2012) Hemofiltration compared to hemodialysis for acute kidney injury: systematic review and meta-analysis. Crit Care 16:R146
Hartmann B, Czock D, Keller F (2010) Drug therapy in patients with chronic renal failure. Dtsch Arztebl Int 107:647–655
Heintz BH, Matzke GR, Dager WE (2009) Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis. Pharmacotherapy 29:562–577
Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honoré PM, Joannes-Boyau O, Joannidis M, Korhonen AM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Andrade VE, Webb S, Kellum JA (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41:1411–1423
Jamal JA, Udy AA, Lipman J, Roberts JA (2014) The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens. Crit Care Med 42:1640–1650
Kalb R, Kram R, Morgera S, Slowinski T, Kindgen-Milles D (2013) Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk. Ther Apher Dial 17:202–212
Kunin CM (1967) A guide to use of antibiotics in patients with renal disease. A table of recommended doses and factors governing serum levels. Ann Intern Med 67:151–158
Martinez MN, Papich MG, Drusano GL (2012) Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target. Antimicrob Agents Chemother 56:2795–2805
Matzke GR, Aronoff GR, Atkinson AJ Jr, Bennett WM, Decker BS, Eckardt KU, Golper T, Grabe DW, Kasiske B, Keller F, Kielstein JT, Mehta R, Mueller BA, Pasko DA, Schaefer F, Sica DA, Inker LA, Umans JG, Murray P (2011) Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 80:1122–1137
MIC- and Inhibition zone diameter distributions of microorganisms without and with resistance mechanisms. http://mic.eucast.org/Eucast2/. Zugegriffen: 05. März 2018
Norton K, Ingram PR, Heath CH, Manning L (2014) Risk factors for nephrotoxicity in patients receiving outpatient continuous infusions of vancomycin in an Australian tertiary hospital. J Antimicrob Chemother 69:805–808
Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359:7–20
Pea F, Viale P, Furlanut M (2005) Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability. Clin Pharmacokinet 44:1009–1034
Seyler L, Cotton F, Taccone FS, De Backer D, Macours P, Vincent JL, Jacobs F (2011) Recommended β‑lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy. Crit Care 15:R137
Tian Q, Gomersall CD, Ip M, Tan PE, Joynt GM, Choi GY (2008) Adsorption of amikacin, a significant mechanism of elimination by hemofiltration. Antimicrob Agents Chemother 52:1009–1013
Udy AA, Baptista JP, Lim NL, Joynt GM, Jarrett P, Wockner L, Boots RJ, Lipman J (2014) Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations. Crit Care Med 42:520–527
Vandecasteele SJ, De Vriese AS, Tacconelli E (2013) The pharmacokinetics and pharmacodynamics of vancomycin in clinical practice: evidence and uncertainties. J Antimicrob Chemother 68:743–748
Varma MV, Feng B, Obach RS, Troutman MD, Chupka J, Miller HR, El-Kattan A (2009) Physicochemical determinants of human renal clearance. J Med Chem 52:4844–4852
Vilay AM, Churchwell MD, Mueller BA (2008) Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury. Crit Care 12:235